Showing 11,721 - 11,740 results of 123,048 for search '(( 2 d decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.24s Refine Results
  1. 11721
  2. 11722
  3. 11723
  4. 11724
  5. 11725
  6. 11726
  7. 11727
  8. 11728
  9. 11729
  10. 11730
  11. 11731
  12. 11732
  13. 11733

    Three-Dimensional Extended Frameworks Constructed from Dinuclear Lanthanide(III) 1,4-Naphthalenedicarboxylate Units with Bis(2,2′-biimidazole) Templates: Syntheses, Structures, and... by Ying-Bing Lu (1826701)

    Published 2014
    “…Complexes <b>1</b>–<b>8</b> crystallize in the monoclinic space group <i>P</i>2<sub>1</sub>/<i>c</i> and display similar (8,8)-connected 3-D frameworks with different dinuclear Ln secondary building units due to the effect of Ln contraction and diverse coordination modes of NDC<sup>2–</sup> ligands. …”
  14. 11734

    Decreased survival of SCLC patients with moderate CEA expression levels. by Franziska Heidemann (546600)

    Published 2014
    “…Three patient groups were discriminated: (D) no CEA expression (CEA−), (E) moderate CEA expression (CEA+) and (F) strong CEA expression (CEA++). …”
  15. 11735

    DCIR ligand binding results in decreased phosphorylation of the ITIM in DCIR. by Karien Bloem (420391)

    Published 2013
    “…(B) The relative α-PY20 intensity is calculated by dividing the raw intensity of α-PY20-specific signal in the DCIR immunoprecipitations by the raw intensity of the α-DCIR-specific signal from the corresponding DCIR immunoprecipitations. One experiment out of two independent experiments is shown. (C) DCIR ligand binding results in decreased phosphorylation of the ITIM in DCIR. …”
  16. 11736
  17. 11737

    Comparison of our CCR5-CCL5-I and -II systems with the experimental structure (PDB ID: 7O7F), a complex of CCR5 with a modified CCL5 chemokine, the super-agonist [6P4]CCL5. by Guillermo Goode-Romero (11476663)

    Published 2022
    “…<i>e</i>., helices and beta-sheets) were calculated on our trajectory with respect 7O7F. The predominant decrease in the RMSD of replicate I suggests that our system approximates to the full activated state, despite the bias introduced by the CCL5 mutations in 7O7F. …”
  18. 11738

    Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4<sup>+</sup> T lymphocytes by Sandra M. Gonzalez (7423307)

    Published 2019
    “…In this regard, it has been proposed that immunomodulatory compounds capable of modulating immune activation, such as Vitamin D (VitD) may reduce HIV-1 transmission and might be used as a safe and cost-effective strategy for prevention. …”
  19. 11739
  20. 11740

    Statistical index <i>η</i> as a function of <i>I</i><sub><i>CaL</i></sub> for different values of <i>I</i><sub><i>Kr</i></sub>. by Enid Van Nieuwenhuyse (4669237)

    Published 2017
    “…<p>The calculation of <i>η</i> for a threshold of -60 mV and the last second of the burst pacing simulation. …”